
Electrophysiology Ablation Catheters Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update
Description
Electrophysiology Ablation Catheters Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update
Summary
GlobalData's Medical Devices sector report, “Electrophysiology Ablation Catheters Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update provides comprehensive information about the Electrophysiology Ablation Catheters pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.
An electrophysiology ablation catheter contains an electrode on one end which emits RF waves to destroy a small area of heart tissue in the abnormal conduction pathway, blocking further channeling of the impulses causing the heart’s abnormal rhythm.
Note:Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.
Scope
- Extensive coverage of the Electrophysiology Ablation Catheters under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Electrophysiology Ablation Catheters and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry
The report enables you to -
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
- Identify and understand important and diverse types of Electrophysiology Ablation Catheters under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product’s current stage of development, territory and estimated launch date
Table of Contents
134 Pages
- 1 About GlobalData
- 2 Table of Contents
- 2.1 List of Tables
- 2.2 List of Figures
- 3 Introduction
- 3.1 Electrophysiology Ablation Catheters Overview
- 4 Products under Development
- 4.1 Electrophysiology Ablation Catheters - Pipeline Products by Stage of Development
- 4.2 Electrophysiology Ablation Catheters - Pipeline Products by Segment
- 4.3 Electrophysiology Ablation Catheters - Pipeline Products by Territory
- 4.4 Electrophysiology Ablation Catheters - Pipeline Products by Regulatory Path
- 4.5 Electrophysiology Ablation Catheters - Pipeline Products by Estimated Approval Date
- 4.6 Electrophysiology Ablation Catheters - Ongoing Clinical Trials
- 5 Electrophysiology Ablation Catheters - Pipeline Products under Development by Companies
- 5.1 Electrophysiology Ablation Catheters Companies - Pipeline Products by Stage of Development
- 5.2 Electrophysiology Ablation Catheters – Companies Pipeline Products by Stage of Development
- 6 Electrophysiology Ablation Catheters Companies and Product Overview
- 6.1 Ablacon Inc Company Overview
- 6.1.1 Ablacon Inc Pipeline Products & Ongoing Clinical Trials Overview
- 6.2 Acotec Scientific Co Ltd Company Overview
- 6.2.1 Acotec Scientific Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
- 6.3 Adagio Medical Inc. Company Overview
- 6.3.1 Adagio Medical Inc. Pipeline Products & Ongoing Clinical Trials Overview
- 6.4 Apama Medical Inc Company Overview
- 6.4.1 Apama Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
- 6.5 APT Medical Inc Company Overview
- 6.5.1 APT Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
- 6.6 Biosense Webster Inc Company Overview
- 6.6.1 Biosense Webster Inc Pipeline Products & Ongoing Clinical Trials Overview
- 6.7 BioTex Inc Company Overview
- 6.7.1 BioTex Inc Pipeline Products & Ongoing Clinical Trials Overview
- 6.8 Boston Scientific Corp Company Overview
- 6.8.1 Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview
- 6.9 CardioFocus Inc Company Overview
- 6.9.1 CardioFocus Inc Pipeline Products & Ongoing Clinical Trials Overview
- 6.1 CardioNova Ltd Company Overview
- 6.10.1 CardioNova Ltd Pipeline Products & Ongoing Clinical Trials Overview
- 6.11 CathEffects LLC Company Overview
- 6.11.1 CathEffects LLC Pipeline Products & Ongoing Clinical Trials Overview
- 6.12 CathRx Ltd Company Overview
- 6.12.1 CathRx Ltd Pipeline Products & Ongoing Clinical Trials Overview
- 6.13 Cibiem, Inc. Company Overview
- 6.13.1 Cibiem, Inc. Pipeline Products & Ongoing Clinical Trials Overview
- 6.14 Columbia University Company Overview
- 6.14.1 Columbia University Pipeline Products & Ongoing Clinical Trials Overview
- 6.15 Cordis US Corp Company Overview
- 6.15.1 Cordis US Corp Pipeline Products & Ongoing Clinical Trials Overview
- 6.16 CoreMap Inc Company Overview
- 6.16.1 CoreMap Inc Pipeline Products & Ongoing Clinical Trials Overview
- 6.17 Coridea, LLC Company Overview
- 6.17.1 Coridea, LLC Pipeline Products & Ongoing Clinical Trials Overview
- 6.18 CryoTherapeutics SA Company Overview
- 6.18.1 CryoTherapeutics SA Pipeline Products & Ongoing Clinical Trials Overview
- 6.19 Epicardial Technologies Inc (Inactive) Company Overview
- 6.19.1 Epicardial Technologies Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
- 6.2 Ethicon US LLC Company Overview
- 6.20.1 Ethicon US LLC Pipeline Products & Ongoing Clinical Trials Overview
- 6.21 Farapulse Inc Company Overview
- 6.21.1 Farapulse Inc Pipeline Products & Ongoing Clinical Trials Overview
- 6.22 FocusStart LLC Company Overview
- 6.22.1 FocusStart LLC Pipeline Products & Ongoing Clinical Trials Overview
- 6.23 Galvanize Therapeutics Inc Company Overview
- 6.23.1 Galvanize Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview
- 6.24 Hansen Medical Inc (Inactive) Company Overview
- 6.24.1 Hansen Medical Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
- 6.25 Hyblate Medical Company Overview
- 6.25.1 Hyblate Medical Pipeline Products & Ongoing Clinical Trials Overview
- 6.26 Imricor Medical Systems Inc Company Overview
- 6.26.1 Imricor Medical Systems Inc Pipeline Products & Ongoing Clinical Trials Overview
- 6.27 Interventional Imaging, Inc. Company Overview
- 6.27.1 Interventional Imaging, Inc. Pipeline Products & Ongoing Clinical Trials Overview
- 6.28 Iowa Approach Inc. Company Overview
- 6.28.1 Iowa Approach Inc. Pipeline Products & Ongoing Clinical Trials Overview
- 6.29 Japan Lifeline Co Ltd Company Overview
- 6.29.1 Japan Lifeline Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
- 6.3 Maestro Heart SA Company Overview
- 6.30.1 Maestro Heart SA Pipeline Products & Ongoing Clinical Trials Overview
- 6.31 Medlumics SL Company Overview
- 6.31.1 Medlumics SL Pipeline Products & Ongoing Clinical Trials Overview
- 6.32 MedWaves Inc Company Overview
- 6.32.1 MedWaves Inc Pipeline Products & Ongoing Clinical Trials Overview
- 6.33 MicroPort Scientific Corp Company Overview
- 6.33.1 MicroPort Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview
- 6.34 Northwestern University Company Overview
- 6.34.1 Northwestern University Pipeline Products & Ongoing Clinical Trials Overview
- 6.35 Novasentis Inc Company Overview
- 6.35.1 Novasentis Inc Pipeline Products & Ongoing Clinical Trials Overview
- 6.36 OrbusNeich Company Overview
- 6.36.1 OrbusNeich Pipeline Products & Ongoing Clinical Trials Overview
- 6.37 SCR, Inc. Company Overview
- 6.37.1 SCR, Inc. Pipeline Products & Ongoing Clinical Trials Overview
- 6.38 Seattle Children's Hospital Company Overview
- 6.38.1 Seattle Children's Hospital Pipeline Products & Ongoing Clinical Trials Overview
- 6.39 Shanghai HeartCare Medical Technology Co Ltd Company Overview
- 6.39.1 Shanghai HeartCare Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
- 6.4 Shanghai MicroPort EP MedTech Co Ltd Company Overview
- 6.40.1 Shanghai MicroPort EP MedTech Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
- 6.41 St. Jude Medical LLC Company Overview
- 6.41.1 St. Jude Medical LLC Pipeline Products & Ongoing Clinical Trials Overview
- 6.42 Stereotaxis Inc Company Overview
- 6.42.1 Stereotaxis Inc Pipeline Products & Ongoing Clinical Trials Overview
- 6.43 University of Arkansas at Little Rock Company Overview
- 6.43.1 University of Arkansas at Little Rock Pipeline Products & Ongoing Clinical Trials Overview
- 6.44 University of Michigan Company Overview
- 6.44.1 University of Michigan Pipeline Products & Ongoing Clinical Trials Overview
- 6.45 University of Rochester Company Overview
- 6.45.1 University of Rochester Pipeline Products & Ongoing Clinical Trials Overview
- 6.46 University of Texas Medical Branch at Galveston Company Overview
- 6.46.1 University of Texas Medical Branch at Galveston Pipeline Products & Ongoing Clinical Trials Overview
- 6.47 Vanderbilt University Company Overview
- 6.47.1 Vanderbilt University Pipeline Products & Ongoing Clinical Trials Overview
- 6.48 Vimecon GmbH Company Overview
- 6.48.1 Vimecon GmbH Pipeline Products & Ongoing Clinical Trials Overview
- 6.49 Vivonics Inc Company Overview
- 6.49.1 Vivonics Inc Pipeline Products & Ongoing Clinical Trials Overview
- 6.5 Voyage Medical (Inactive) Company Overview
- 6.50.1 Voyage Medical (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
- 7 Electrophysiology Ablation Catheters- Recent Developments
- 7.1 Mar 12, 2024: Medtronic To Present At Barclays Global Healthcare Conference
- 7.2 Mar 04, 2024: Medtronic Receives 510(k) Clearance for OsteoCool 2.0 RF Ablation System
- 7.3 Mar 04, 2024: Stereotaxis Announces Regulatory Submissions of the MAGiC Ablation Catheter in Europe and the United States
- 7.4 Feb 28, 2024: Boston Scientific Raises $2.2B to Support Purchase of California Medical Device Company
- 7.5 Feb 23, 2024: Medical Tech Leader, Boston Scientific (BSX), Announces Notes Offering
- 7.6 Feb 19, 2024: Boston Scientific Appoints Madan Krishnan to Lead India Subcontinent
- 7.7 Feb 16, 2024: Jim Robo, Former Chairman and CEO of NextEra Energy, to Join Mayo Clinic Board of Trustees
- 7.8 Feb 14, 2024: GE HealthCare Management to Present at Upcoming Investor Conferences
- 7.9 Feb 06, 2024: INSERTING and REPLACING GE HealthCare Reports Fourth Quarter and Full Year 2023 Financial Results
- 7.1 Feb 01, 2024: S4 Medical Announces Publication of EASY AF Clinical Study Results Showing Significant Esophageal Injury Reduction in JACC: Electrophysiology
- 7.11 Feb 01, 2024: Japan Lifeline Announces an Appointment of a New Operating Officer
- 7.12 Jan 31, 2024: Boston Scientific Announces Results for Fourth Quarter and Full Year 2023
- 7.13 Jan 18, 2024: GE HealthCare to Announce Fourth Quarter and Full Year 2023 Results on February 6, 2024
- 7.14 Jan 08, 2024: Stereotaxis Announces First Patients Successfully Treated using MAGiC Ablation Catheter
- 7.15 Jan 05, 2024: Boston Scientific Announces Conference Call Discussing Fourth Quarter 2023 Results
- 7.16 Dec 14, 2023: Biosense Webster Begins Enrollment of SmartPulse Study in the U.S. to Evaluate RF and PFA Dual Energy Catheter to Treat Atrial Fibrillation
- 7.17 Dec 11, 2023: MicroPort Scientific : Voluntary Announcement
- 7.18 Dec 01, 2023: Japan Lifeline Announces Changes in Organization and Personnel
- 7.19 Nov 10, 2023: Microport Appointment of Director
- 7.2 Nov 06, 2023: MicroPort EP Participates in LAHRS 2023
- 7.21 Nov 04, 2023: MicroPort EP Participates in 2023 World Congress of Arrhythmias
- 7.22 Oct 31, 2023: GE HealthCare Reports Third Quarter 2023 Financial Results
- 7.23 Oct 26, 2023: Boston Scientific Announces Results for Third Quarter 2023
- 7.24 Oct 04, 2023: Stereotaxis Robotic Technology to be Featured during 7th Annual Meeting of the Society for Cardiac Robotic Navigation
- 7.25 Oct 04, 2023: Medtronic Names Paolo Di Vincenzo President of the Neuromodulation Business
- 7.26 Sep 21, 2023: Microport Scientific Corp. Announces 2023 Interim Report
- 7.27 Sep 19, 2023: Microport EP Receives Approval for Firemagic Trueforce Ablation Catheter in EU and UK
- 7.28 Sep 14, 2023: Adagio announces first procedure with vCLAS catheter system
- 7.29 Sep 14, 2023: Adagio Medical Announces Initiation and First Procedure in FULCRUM-VT Trial, Starting The Process For Bringing Ultra-Low Temperature Cryoablation for Ventricular Arrhythmias to US Market
- 7.3 Sep 01, 2023: Japan Lifeline Announces Changes in Organizations and Personnel
- 7.31 Aug 26, 2023: Medtronic Q2 2024 Earnings Estimates Increased by William Blair
- 7.32 Aug 23, 2023: Boston Scientific Obtains Pre-Market Approval (PMA) for POLARx FIT Cryoablation Balloon Catheter
- 7.33 Aug 17, 2023: Mayo Clinic Reports Strong Finances for 2023 So Far with Q2 Revenue of $4.47 billion
- 7.34 Aug 11, 2023: Kristin Peck, CEO of Zoetis, to join Mayo Clinic Board of Trustees
- 7.35 Aug 08, 2023: Medtronic to Announce Financial Results for its First Quarter of Fiscal Year 2024
- 7.36 Aug 07, 2023: FDA approves J&J’s Afib ablation devices for use without fluoroscopy
- 7.37 Jul 19, 2023: Biosense Webster Completes Enrollment in Pivotal Trial Evaluating PFA and RF Dual Energy Catheter for Patients with Atrial Fibrillation in Europe
- 7.38 Jul 19, 2023: Boston Scientific lays off 52 workers as it closes another Silicon Valley facility
- 7.39 Jul 18, 2023: Imricor Receives US$1 Million Commitment Letter from North Dakota Development Fund
- 7.4 Jul 11, 2023: Microport Scientific Provides Consolidated Earnings Guidance for the Six Months Ended June 30, 2023
- 7.41 Jul 02, 2023: Imricor Signs Landmark Agreement With Leading Distributor In Saudi Arabia
- 7.42 Jun 15, 2023: Stereotaxis to Initiate First-In-Human Trial to Support CE Mark Application of Magic Catheter
- 7.43 Jun 09, 2023: MicroPort EP Exhibiting at the Heart Rhythm Society Annual Meeting
- 7.44 May 18, 2023: MicroPort CRM and MicroPort EP were presented at the 2023 Annual Meeting of the European Heart Rhythm Association
- 7.45 May 15, 2023: New data published on Biosense Webster QDOT MICRO catheter - the latest advancement in Focal RF ablation for treating AFib
- 7.46 May 11, 2023: Medtronic to announce financial results for its fourth quarter and full fiscal year 2023
- 7.47 May 09, 2023: GE HealthCare Names James Saccaro Vice President and Chief Financial Officer
- 7.48 Apr 26, 2023: MicroPort announces annual results for 2022
- 7.49 Apr 25, 2023: Cryofocus Medtech Shanghai Co. Announces 2022 Annual Report
- 7.5 Apr 12, 2023: Medtronic has a layoff in California
- 7.51 Apr 06, 2023: Ablacon receives 510(k) clearance for Ablacath Mapping Catheter
- 8 Appendix
- 8.1 Methodology
- 8.2 About GlobalData
- 8.3 Contact Us
- 8.4 Disclaimer
- 2.1 List of Tables
- Table 1: Electrophysiology Ablation Catheters - Pipeline Products by Stage of Development
- Table 2: Electrophysiology Ablation Catheters - Pipeline Products by Segment
- Table 3: Electrophysiology Ablation Catheters - Pipeline Products by Territory
- Table 4: Electrophysiology Ablation Catheters - Pipeline Products by Regulatory Path
- Table 5: Electrophysiology Ablation Catheters - Pipeline Products by Estimated Approval Date
- Table 6: Electrophysiology Ablation Catheters - Ongoing Clinical Trials
- Table 7: Electrophysiology Ablation Catheters Companies - Pipeline Products by Stage of Development
- Table 8: Electrophysiology Ablation Catheters – Companies Pipeline Products by Stage of Development
- Table 9: Ablacon Inc Pipeline Products & Ongoing Clinical Trials Overview
- Table 10: Ablasense - Product Status
- Table 11: Ablasense - Product Description
- Table 12: Acotec Scientific Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
- Table 13: ERA-C30 Endovenous Radiofrequency Closure Catheter - Product Status
- Table 14: ERA-C30 Endovenous Radiofrequency Closure Catheter - Product Description
- Table 15: ERA-C70 Endovenous Radiofrequency Closure Catheter - Product Status
- Table 16: ERA-C70 Endovenous Radiofrequency Closure Catheter - Product Description
- Table 17: ERA-G5 Endovenous Radiofrequency Closure Generator - Product Status
- Table 18: ERA-G5 Endovenous Radiofrequency Closure Generator - Product Description
- Table 19: Adagio Medical Inc. Pipeline Products & Ongoing Clinical Trials Overview
- Table 20: vCLAS VT Ablation Catheter - Product Status
- Table 21: vCLAS VT Ablation Catheter - Product Description
- Table 22: Apama Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
- Table 23: LUMINIZE Radiofrequency (RF) Balloon Catheter - Product Status
- Table 24: LUMINIZE Radiofrequency (RF) Balloon Catheter - Product Description
- Table 25: APT Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
- Table 26: Magnetic Positioning Pressure Sensing Radiofrequency Ablation Catheter - Product Status
- Table 27: Magnetic Positioning Pressure Sensing Radiofrequency Ablation Catheter - Product Description
- Table 28: Pressure Sensing Ablation Catheter - Product Status
- Table 29: Pressure Sensing Ablation Catheter - Product Description
- Table 30: RF Ablation Device with Pressure Sensing - Product Status
- Table 31: RF Ablation Device with Pressure Sensing - Product Description
- Table 32: Biosense Webster Inc Pipeline Products & Ongoing Clinical Trials Overview
- Table 33: CARTO SMARTTOUCH 5D Catheter - Product Status
- Table 34: CARTO SMARTTOUCH 5D Catheter - Product Description
- Table 35: Heliostar Multi-Electrode Radiofrequency Balloon Ablation Catheter - Product Status
- Table 36: Heliostar Multi-Electrode Radiofrequency Balloon Ablation Catheter - Product Description
- Table 37: Thermocool Smarttouch SF Dual Energy Catheter - Product Status
- Table 38: Thermocool Smarttouch SF Dual Energy Catheter - Product Description
- Table 39: Biosense Webster Inc - Ongoing Clinical Trials Overview
- Table 40: Heliostar Multi-Electrode Radiofrequency Balloon Ablation Catheter - Implementation of the HELIOSTAR in Real-world Clinical Practice at a High-volume Center - Operator Learning Curve and Procedural Outcome Parameters
- Table 41: CARTO SMARTTOUCH 5D Catheter - Ground-Breaking Electroporation-based Intervention for PERSistent Atrial Fibrillation Treatment (BEAT PERS-AF)
- Table 42: Thermocool Smarttouch SF Dual Energy Catheter - Safety and Effectiveness Evaluation of the THERMOCOOL SMARTTOUCH SF Catheter With the TRUPULSE Generator for Treatment of Drug Refractory Symptomatic Paroxysmal Atrial Fibrillation (PAF)
- Table 43: BioTex Inc Pipeline Products & Ongoing Clinical Trials Overview
- Table 44: Cooled Tip Catheter - Product Status
- Table 45: Cooled Tip Catheter - Product Description
- Table 46: Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview
- Table 47: Next Generation Blazer Catheter - Product Status
- Table 48: Next Generation Blazer Catheter - Product Description
- Table 49: Next Generation IntellaTip Catheter - Product Status
- Table 50: Next Generation IntellaTip Catheter - Product Description
- Table 51: POLARx Next Generation Catheter - Product Status
- Table 52: POLARx Next Generation Catheter - Product Description
- Table 53: CardioFocus Inc Pipeline Products & Ongoing Clinical Trials Overview
- Table 54: HeartLight X3 System - Product Status
- Table 55: HeartLight X3 System - Product Description
- Table 56: CardioFocus Inc - Ongoing Clinical Trials Overview
- Table 57: HeartLight X3 System - A Prospective Multicenter U.S. Comparison of Radiofrequency, Cryoballoon and Laser Balloon Modalities for Pulmonary Vein Isolation Ablation in Patients with Atrial Fibrillation
- Table 58: CardioNova Ltd Pipeline Products & Ongoing Clinical Trials Overview
- Table 59: CardioNova System - Product Status
- Table 60: CardioNova System - Product Description
- Table 61: CathEffects LLC Pipeline Products & Ongoing Clinical Trials Overview
- Table 62: Desai VectorCathRF1 Mapping And Ablation Catheter - Product Status
- Table 63: Desai VectorCathRF1 Mapping And Ablation Catheter - Product Description
- Table 64: CathRx Ltd Pipeline Products & Ongoing Clinical Trials Overview
- Table 65: CathRx 4mm Therapeutic Catheter - Product Status
- Table 66: CathRx 4mm Therapeutic Catheter - Product Description
- Table 67: CathRx 8mm Therapeutic Catheter - Product Status
- Table 68: CathRx 8mm Therapeutic Catheter - Product Description
- Table 69: Khelix Irrigated Ablation EP Catheter - Product Status
- Table 70: Khelix Irrigated Ablation EP Catheter - Product Description
- Table 71: Khelix Non-Irrigated Ablation EP Catheter - Product Status
- Table 72: Khelix Non-Irrigated Ablation EP Catheter - Product Description
- Table 73: Cibiem, Inc. Pipeline Products & Ongoing Clinical Trials Overview
- Table 74: Catheter-Based Carotid Body Ablation System - Product Status
- Table 75: Catheter-Based Carotid Body Ablation System - Product Description
- Table 76: Columbia University Pipeline Products & Ongoing Clinical Trials Overview
- Table 77: Optically-Integrated RFA Catheter - Product Status
- Table 78: Optically-Integrated RFA Catheter - Product Description
- Table 79: Cordis US Corp Pipeline Products & Ongoing Clinical Trials Overview
- Table 80: EP Contact Force Sensing Catheter Enabled By CARTO 3 - Product Status
- Table 81: EP Contact Force Sensing Catheter Enabled By CARTO 3 - Product Description
- Table 82: CoreMap Inc Pipeline Products & Ongoing Clinical Trials Overview
- Table 83: Electrophysiology Mapping System - Atrial Fibrillation - Product Status
- Table 84: Electrophysiology Mapping System - Atrial Fibrillation - Product Description
- Table 85: Coridea, LLC Pipeline Products & Ongoing Clinical Trials Overview
- Table 86: High Intensity Therapeutic Ultrasound Catheter - Obstructive Hypertrophic Cardiomyopathy - Product Status
- Table 87: High Intensity Therapeutic Ultrasound Catheter - Obstructive Hypertrophic Cardiomyopathy - Product Description
- Table 88: CryoTherapeutics SA Pipeline Products & Ongoing Clinical Trials Overview
- Table 89: Cryotherapy System - Coronary Artery Disease - Product Status
- Table 90: Cryotherapy System - Coronary Artery Disease - Product Description
- Table 91: CryoTherapeutics SA - Ongoing Clinical Trials Overview
- Table 92: Cryotherapy System - Coronary Artery Disease - Clinical Investigation of Intracoronary Cryotherapy Using the CryoTherapy System (CTS) for High-risk Plaque in Patients with Non-ST Segment Elevation Myocardial Infarction (NSTEMI) or Unstable Angina
- Table 93: Epicardial Technologies Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
- Table 94: Epicardial Access Device - Product Status
- Table 95: Epicardial Access Device - Product Description
- Table 96: Ethicon US LLC Pipeline Products & Ongoing Clinical Trials Overview
- Table 97: Next Generation Ablation Catheter - Product Status
- Table 98: Next Generation Ablation Catheter - Product Description
- Table 99: Farapulse Inc Pipeline Products & Ongoing Clinical Trials Overview
- Table 100: FARAFLEX - Product Status
- Table 101: FARAFLEX - Product Description
- Table 102: FARAONE - Product Status
- Table 103: FARAONE - Product Description
- Table 104: FARAPOINT - Product Status
- Table 105: FARAPOINT - Product Description
- Table 106: FARAWAVE Nav - Product Status
- Table 107: FARAWAVE Nav - Product Description
- Table 108: Next Gen FARAWAVE Catheter - Product Status
- Table 109: Next Gen FARAWAVE Catheter - Product Description
- Table 110: FocusStart LLC Pipeline Products & Ongoing Clinical Trials Overview
- Table 111: Anti-coagulum Cardiac Ablation Catheter - Product Status
- Table 112: Anti-coagulum Cardiac Ablation Catheter - Product Description
- Table 113: Galvanize Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview
- Table 114: QuickShot - Product Status
- Table 115: QuickShot - Product Description
- Table 116: Galvanize Therapeutics Inc - Ongoing Clinical Trials Overview
- Table 117: QuickShot - The First Human Use of QuickShot - A Novel Contact-Sensing, Large Area, Focal Pulsed Electric Field Mapping & Ablation Catheter
- Table 118: Hansen Medical Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
- Table 119: Sensei X Robotic Catheter System - Atrial Fibrillation - Product Status
- Table 120: Sensei X Robotic Catheter System - Atrial Fibrillation - Product Description
- Table 121: Hyblate Medical Pipeline Products & Ongoing Clinical Trials Overview
- Table 122: Hybrid Ablation Catheter - Product Status
- Table 123: Hybrid Ablation Catheter - Product Description
- Table 124: Imricor Medical Systems Inc Pipeline Products & Ongoing Clinical Trials Overview
- Table 125: Vision-MR Ablation Catheter - Product Status
- Table 126: Vision-MR Ablation Catheter - Product Description
- Table 127: Vision-MR Ablation Catheter 2.0 - Product Status 6
- Table 128: Vision-MR Ablation Catheter 2.0 - Product Description 6
- Table 129: Imricor Medical Systems Inc - Ongoing Clinical Trials Overview 6
- Table 130: Vision-MR Ablation Catheter 2.0 - Vision-MR Ablation Catheter 2.0 for the Treatment of Ventricular Tachycardia
- Table 131: Vision-MR Ablation Catheter 2.0 - Vision-MR Ablation Catheter 2.0 for Treatment of Type I Atrial Flutter
- Table 132: Interventional Imaging, Inc. Pipeline Products & Ongoing Clinical Trials Overview
- Table 133: Atrial Fibrillation Catheter - Product Status
- Table 134: Atrial Fibrillation Catheter - Product Description
- Table 135: Iowa Approach Inc. Pipeline Products & Ongoing Clinical Trials Overview
- Table 136: MaPP-CS - Product Status
- Table 137: MaPP-CS - Product Description
- Table 138: ROF-AC - Product Status
- Table 139: ROF-AC - Product Description
- Table 140: ROF-AS - Product Status
- Table 141: ROF-AS - Product Description
- Table 142: Japan Lifeline Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
- Table 143: ALPHA1 Ablation Catheter - Product Status
- Table 144: ALPHA1 Ablation Catheter - Product Description
- Table 145: Maestro Heart SA Pipeline Products & Ongoing Clinical Trials Overview
- Table 146: Maestro-AF Catheter System - Product Status
- Table 147: Maestro-AF Catheter System - Product Description
- Table 148: Medlumics SL Pipeline Products & Ongoing Clinical Trials Overview
- Table 149: AblaView - Product Status
- Table 150: AblaView - Product Description
- Table 151: MedWaves Inc Pipeline Products & Ongoing Clinical Trials Overview
- Table 152: Arrhythmia Catheters - Product Status
- Table 153: Arrhythmia Catheters - Product Description
- Table 154: MicroPort Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 6
- Table 155: Circular Ablation Catheter - Product Status 6
- Table 156: Circular Ablation Catheter - Product Description 6
- Table 157: Voyager Irrigated RF Ablation Catheter - Product Status 7
- Table 158: Voyager Irrigated RF Ablation Catheter - Product Description 7
- Table 159: Northwestern University Pipeline Products & Ongoing Clinical Trials Overview
- Table 160: Cardiac Catheter - Product Status
- Table 161: Cardiac Catheter - Product Description
- Table 162: Novasentis Inc Pipeline Products & Ongoing Clinical Trials Overview
- Table 163: Electroactive Polymer Based Steerable Catheter - Product Status
- Table 164: Electroactive Polymer Based Steerable Catheter - Product Description
- Table 165: OrbusNeich Pipeline Products & Ongoing Clinical Trials Overview
- Table 166: Ablation Catheter - Product Status(OrbusNeich)
- Table 167: Ablation Catheter - Product Description(OrbusNeich)
- Table 168: SCR, Inc. Pipeline Products & Ongoing Clinical Trials Overview
- Table 169: Atrial Fibrillation Device - Product Status
- Table 170: Atrial Fibrillation Device - Product Description
- Table 171: Seattle Children's Hospital Pipeline Products & Ongoing Clinical Trials Overview
- Table 172: Ablation Catheter - Heart Arrhythmia - Product Status
- Table 173: Ablation Catheter - Heart Arrhythmia - Product Description
- Table 174: Shanghai HeartCare Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
- Table 175: Cryoablation Catheter - Product Status
- Table 176: Cryoablation Catheter - Product Description
- Table 177: Shanghai MicroPort EP MedTech Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
- Table 178: Contact Force-Sensing RF Ablation Catheter - Product Status
- Table 179: Contact Force-Sensing RF Ablation Catheter - Product Description
- Table 180: Shanghai MicroPort EP MedTech Co Ltd - Ongoing Clinical Trials Overview
- Table 181: Contact Force-Sensing RF Ablation Catheter - A Multicenter Clinical Study of Pulsed Electric Field Ablation Device and Force Sensing Pulsed Field Ablation Catheter for the Treatment of Paroxysmal Supraventricular Tachycardia Under the Guidance of Columbus 3D EP Navigation System
- Table 182: St. Jude Medical LLC Pipeline Products & Ongoing Clinical Trials Overview 6
- Table 183: FlexAbility Irrigated Ablation Catheter Sensor Enabled - Monomorphic Ventricular Tachycardia - Product Status 6
- Table 184: FlexAbility Irrigated Ablation Catheter Sensor Enabled - Monomorphic Ventricular Tachycardia - Product Description 7
- Table 185: St. Jude Medical LLC - Ongoing Clinical Trials Overview 7
- Table 186: FlexAbility Irrigated Ablation Catheter Sensor Enabled - Monomorphic Ventricular Tachycardia - Flexability Sensor Enabled Substrate Targeted Ablation for the Reduction of Ventricular Tachycardia (LESS-VT) Study 7
- Table 187: Stereotaxis Inc Pipeline Products & Ongoing Clinical Trials Overview 8
- Table 188: MAGiC Ablation Catheter - Product Status 8
- Table 189: MAGiC Ablation Catheter - Product Description 8
- Table 190: Next Generation Irrigated Magnetic Catheter - Product Status
- Table 191: Next Generation Irrigated Magnetic Catheter - Product Description
- Table 192: Stereotaxis Inc - Ongoing Clinical Trials Overview
- Table 193: MAGiC Ablation Catheter - The MAGiC Cardiac Ablation Feasibility Study
- Table 194: University of Arkansas at Little Rock Pipeline Products & Ongoing Clinical Trials Overview
- Table 195: Robotic Catheter - Product Status
- Table 196: Robotic Catheter - Product Description
- Table 197: University of Michigan Pipeline Products & Ongoing Clinical Trials Overview
- Table 198: Non-Contact Mapping Catheter - Product Status
- Table 199: Non-Contact Mapping Catheter - Product Description
- Table 200: University of Rochester Pipeline Products & Ongoing Clinical Trials Overview
- Table 201: RF Ablation Catheter - Product Status
- Table 202: RF Ablation Catheter - Product Description
- Table 203: University of Texas Medical Branch at Galveston Pipeline Products & Ongoing Clinical Trials Overview
- Table 204: Ablation Catheter - Product Status(University of Texas Medical Branch at Galveston)
- Table 205: Ablation Catheter - Product Description(University of Texas Medical Branch at Galveston)
- Table 206: Vanderbilt University Pipeline Products & Ongoing Clinical Trials Overview
- Table 207: Temperature Controlled Catheter - Product Status
- Table 208: Temperature Controlled Catheter - Product Description
- Table 209: Vimecon GmbH Pipeline Products & Ongoing Clinical Trials Overview 6
- Table 210: Vimecon Laser CAI Catheter - Product Status 6
- Table 211: Vimecon Laser CAI Catheter - Product Description 6
- Table 212: Vivonics Inc Pipeline Products & Ongoing Clinical Trials Overview 7
- Table 213: Catheter Guidance System - Product Status 7
- Table 214: Catheter Guidance System - Product Description 7
- Table 215: Voyage Medical (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 8
- Table 216: IRIS Ablation System - Product Status 8
- Table 217: IRIS Ablation System - Product Description 8
- Table 218: Glossary
- 2.2 List of Figures
- Figure 1: Electrophysiology Ablation Catheters - Pipeline Products by Stage of Development
- Figure 2: Electrophysiology Ablation Catheters - Pipeline Products by Segment
- Figure 3: Electrophysiology Ablation Catheters - Pipeline Products by Territory
- Figure 4: Electrophysiology Ablation Catheters - Pipeline Products by Regulatory Path
- Figure 5: Electrophysiology Ablation Catheters - Pipeline Products by Estimated Approval Date
- Figure 6: Electrophysiology Ablation Catheters - Ongoing Clinical Trials
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.